ÂÜÀòÂÒÂ×

Asaminew Aytenfisu is a highly skilled computational chemist currently working at Deep Genomics since May 2024. Previously held notable positions at ReviR Therapeutics, where contributions as Senior Scientist II led to the integration of "SpliceAI" into the minigene pipeline, significantly enhancing genetic screening efficiency, and advancing drug candidate selection through collaborative molecular docking initiatives. Earlier roles included Senior Scientist I at ReviR Therapeutics and a postdoctoral fellowship at the University of Maryland School of Pharmacy, focusing on computational modeling of antibody-enzyme complexes. Asaminew's academic credentials include a PhD in Biochemistry, Biophysics, and Molecular Biology from the University of Rochester, alongside a postgraduate diploma in Condensed Matter and Materials Physics from the Abdus Salam International Center for Physics and a BSc in Applied Physics from the University of Gondar.